Small island developing States (SIDS) vs Saint Kitts and Nevis: Proportion of the target population who received the final dose of
Small island developing States (SIDS)
22.0%
in 2024
Saint Kitts and Nevis
78.0%
in 2024
Small island developing States (SIDS) rank
25th
Saint Kitts and Nevis rank
28th
Proportion of the target population who received the final dose of over time
- Small island developing States (SIDS)
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 78.0% against 22.0% in Small island developing States (SIDS), a difference of 56.0%.
That makes Saint Kitts and Nevis's figure about 3.5 times Small island developing States (SIDS)'s.
Across all 5 years both countries report, Saint Kitts and Nevis has been ahead every year.
Small island developing States (SIDS) ranks 25th and Saint Kitts and Nevis ranks 28th of 35 groups.
Saint Kitts and Nevis has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Small island developing States (SIDS) or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 78.0% against 22.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Small island developing States (SIDS) and Saint Kitts and Nevis?
- 56.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Small island developing States (SIDS) and Saint Kitts and Nevis?
- 5 years are reported by both, from 2020 to 2024.
- How do Small island developing States (SIDS) and Saint Kitts and Nevis rank globally for proportion of the target population who received the final dose of?
- Small island developing States (SIDS) ranks 25th and Saint Kitts and Nevis ranks 28th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.